AI
BIO icon

Analytic Investors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Analytic Investors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-11,826
Closed -$1.69M – 595
2016
Q2 		$1.69M Sell
11,826
-364
-3% -$51.9K 0.02% 298
2016
Q1 		$1.67M Sell
12,190
-156
-1% -$20.5K 0.02% 330
2015
Q4 		$1.71M Sell
12,346
-11,383
-48% -$1.58M 0.02% 317
2015
Q3 		$3.19M Buy
23,729
+1,787
+8% +$257K 0.04% 236
2015
Q2 		$3.31M Buy
+21,942
New +$3.14M 0.05% 215
2013
Q3 		– Sell
-3,833
Closed -$430K – 508
2013
Q2 		$430K Buy
+3,833
New +$450K 0.01% 460

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Analytic Investors's BIO Position: Q3 2016 in Review

Analytic Investors sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2016, closing a stake of 11,826 shares — an estimated $1.69M sold.

Analytic Investors first reported a position in BIO in Q2 2013 and held it in 6 quarters. The position peaked at $3.31M in Q2 2015. 241 funds tracked by Wall St. Rank hold BIO as of Q3 2016.

  • Analytic Investors reported no remaining Bio-Rad Laboratories Class A position as of Q3 2016 after selling out during the quarter.
  • Analytic Investors sold 11,826 Bio-Rad Laboratories Class A shares in Q3 2016, an estimated $1.69M.
  • Analytic Investors first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 6 quarters.
  • Analytic Investors's Bio-Rad Laboratories Class A position peaked at $3.31M in Q2 2015.
  • 241 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.